Pranav Mody

AZB & Partners

Articles

Results 1 to 5 of 8
Most popular |Most recent


Year in review: a general introduction to merger control issues in India

India - September 7 2020 A general introduction to the most noteworthy features of the merger control regime in India, with particular regard to key developments over the past year.

Aditi Gopalakrishnan, Gaurav Bansal, Varun Thakur.

Spotlight: the merger control regime in India

India - September 7 2020 An examination of the most consequential features of the merger control regime in India, including key phases of review, procedures and appeals.

Aditi Gopalakrishnan, Gaurav Bansal, Varun Thakur.

Snapshot: anticompetitive unilateral conduct in the pharmaceutical sector in India

India - June 30 2020 A look at key practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in India, including IP rights abuse and pricing conduct.

Aditi Gopalakrishnan, Nripi Jolly, Rahul Satyan, Ravi Gangal.

At a glance: pharmaceutical merger review in India

India - June 30 2020 This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in India, including review triggers and thresholds.

Aditi Gopalakrishnan, Nripi Jolly, Rahul Satyan, Ravi Gangal.

In brief: anticompetitive agreements in the pharmaceutical sector in India

India - June 30 2020 The essential legal considerations surrounding anticompetitive agreements in the pharmaceutical sector in India, including the assessment framework and special issues with vertical agreements.

Aditi Gopalakrishnan, Nripi Jolly, Rahul Satyan, Ravi Gangal.